X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (69) 69
male (53) 53
index medicus (47) 47
female (46) 46
adult (40) 40
middle aged (37) 37
infectious diseases (33) 33
hiv (29) 29
hiv infections - drug therapy (22) 22
hepatitis c (18) 18
immunology (18) 18
treatment outcome (17) 17
aged (16) 16
prospective studies (16) 16
therapy (16) 16
drug therapy, combination (15) 15
hepatitis (15) 15
gastroenterology & hepatology (14) 14
hepatitis c, chronic - drug therapy (14) 14
hepatitis c virus (13) 13
ribavirin (13) 13
adolescent (12) 12
antiretroviral therapy (12) 12
antiviral agents (12) 12
drug therapy (12) 12
health aspects (12) 12
infection (12) 12
microbiology (12) 12
patients (12) 12
antiviral agents - therapeutic use (11) 11
hepacivirus - genetics (11) 11
interferon (11) 11
medicine (11) 11
research article (11) 11
virology (11) 11
young adult (11) 11
antiretroviral drugs (10) 10
infections (10) 10
aids (9) 9
cd4 lymphocyte count (9) 9
chronic hepatitis-c (9) 9
genotype (9) 9
human immunodeficiency virus--hiv (9) 9
interferon-alpha - therapeutic use (9) 9
multidisciplinary sciences (9) 9
pharmacokinetics (9) 9
pharmacology & pharmacy (9) 9
ribavirin - therapeutic use (9) 9
risk factors (9) 9
science (9) 9
analysis (8) 8
anti-hiv agents - therapeutic use (8) 8
biological response modifiers (8) 8
drug monitoring (8) 8
germany (8) 8
rna, viral - blood (8) 8
viral load (8) 8
virus-infection (8) 8
viruses (8) 8
acquired immune deficiency syndrome--aids (7) 7
anti-hiv agents - adverse effects (7) 7
antiviral agents - administration & dosage (7) 7
article (7) 7
care and treatment (7) 7
hiv infections - immunology (7) 7
polyethylene glycols - therapeutic use (7) 7
ribavirin - administration & dosage (7) 7
time factors (7) 7
chromatography, high pressure liquid (6) 6
cirrhosis (6) 6
cohort studies (6) 6
disease (6) 6
drugs (6) 6
efavirenz (6) 6
gastroenterology and hepatology (6) 6
genotype & phenotype (6) 6
genotypes (6) 6
hiv infections - virology (6) 6
human immunodeficiency virus (6) 6
liver (6) 6
multivariate analysis (6) 6
recombinant proteins - therapeutic use (6) 6
recurrence (6) 6
sensitivity and specificity (6) 6
telaprevir (6) 6
active antiretroviral therapy (5) 5
anti-hiv agents - administration & dosage (5) 5
antiretroviral agents (5) 5
antiretroviral therapy, highly active (5) 5
boceprevir (5) 5
clinical trials (5) 5
genetic aspects (5) 5
hcv (5) 5
hepatitis c - drug therapy (5) 5
hepatitis c, chronic - virology (5) 5
hepatology (5) 5
hiv infections - blood (5) 5
interferon-alpha - administration & dosage (5) 5
internal medicine (5) 5
liver diseases (5) 5
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Infectious Diseases, The, ISSN 1473-3099, 2017, Volume 17, Issue 2, pp. 215 - 222
Journal Article
MMW - Fortschritte der Medizin, ISSN 1438-3276, 6/2015, Volume 157, Issue S2, pp. 36 - 40
Eine gleichzeitige Infektion mit HIV und dem Hepatitis-C-Virus ist keine Seltenheit. Im Vergleich zu einer HCV-Monoinfektion droht den Betroffenen ein deutlich... 
direct antiviral agents | General Practice / Family Medicine | treatment | Internal Medicine | Medicine & Public Health | HIV-hepatitis-C-co-infection
Journal Article
MMW Fortschritte der Medizin, ISSN 1438-3276, 06/2015, Volume 157, pp. 36 - 40
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 08/2013, Volume 57, p. S125
  Boceprevir and telaprevir are inhibitors and substrates of the cytochrome P450 3A4 family. With the use of these HCV protease inhibitors as part of standard... 
Hepatitis | Drug addiction | Injections | Medical treatment | Mental health | Pharmacology
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 06/2015, Volume 10, Issue 6, pp. e0130277 - e0130277
Background Cancer prevention and therapy in HIV-1-infected patients will play an important role in future. The non-nucleoside reverse transcriptase inhibitors... 
PHARMACOKINETIC INTERACTION | I-131 UPTAKE | MULTIDISCIPLINARY SCIENCES | ACTIVE ANTIRETROVIRAL THERAPY | PROSTATE-CANCER | LINE-1 RETROTRANSPOSITION | HEALTHY-VOLUNTEERS | HIV-1-INFECTED SUBJECTS | HUMAN HEPATIC CELLS | DIFFERENTIATED THYROID-TUMOR | HIV-INFECTED PATIENTS | HIV-1 | Cell Survival - drug effects | HIV Infections - virology | Humans | Reverse Transcriptase Inhibitors - pharmacology | Antineoplastic Agents - therapeutic use | Benzoxazines - therapeutic use | Pancreatic Neoplasms - drug therapy | Reverse Transcriptase Inhibitors - pharmacokinetics | Benzoxazines - pharmacokinetics | Benzoxazines - pharmacology | Cell Line, Tumor | Inhibitory Concentration 50 | HIV Infections - drug therapy | Antineoplastic Agents - pharmacokinetics | Antineoplastic Agents - pharmacology | Cell Proliferation - drug effects | Reverse Transcriptase Inhibitors - therapeutic use | Drug Screening Assays, Antitumor | Antiviral agents | Nevirapine | Pancreatic cancer | Cancer cells | Nucleosides | DNA polymerases | Comparative analysis | Drugs | Flow cytometry | RNA-directed DNA polymerase | Toxicity | Cytotoxicity | Cancer therapies | Efavirenz | Blood | Anticancer properties | Acquired immune deficiency syndrome--AIDS | Nucleoside reverse transcriptase inhibitors | Human immunodeficiency virus--HIV | Biocompatibility | Antiretroviral drugs | Colonies | Tumor cell lines | Patients | Delavirdine | Blood levels | Adenomatous polyposis coli | Non-nucleoside reverse transcriptase inhibitors | Inhibitors | Cell lines | In vivo methods and tests | Cancer | Index Medicus | Acquired immune deficiency syndrome | AIDS | HIV | Human immunodeficiency virus
Journal Article
Liver International, ISSN 1478-3223, 02/2017, Volume 37, Issue 2, pp. 205 - 211
Journal Article
MMW-Fortschritte der Medizin, ISSN 1438-3276, 05/2011, Volume 153, Issue 18, pp. 56 - 59
Journal Article
MMW - Fortschritte der Medizin, ISSN 1438-3276, 05/2011, Volume 153, Issue 18, pp. 56 - 59
Journal Article
AIDS Research and Therapy, ISSN 1742-6405, 01/2015, Volume 12, Issue 1, pp. 1 - 1
Background: While HIV, AIDS and atypical Mycobacterium infections are closely linked, the use of Integrase-Inhibitor based cART, notably raltegravir-based... 
Mycobacterium avium | Chewed | HIV | Pharmacokinetic | Raltegravir | DRUG | INFECTIOUS DISEASES | PHARMACOLOGY | Infection | Usage | Tuberculosis | AIDS (Disease) | HIV patients | Rankings | Rifampin | Carbamazepine | High performance liquid chromatography | Acquired immune deficiency syndrome--AIDS | drug therapy
Journal Article
Journal Article
Gut, ISSN 0017-5749, 10/2017, Volume 66, Issue 10, pp. 1829 - 1837
Journal Article